Revisión de las infusiones continuas y prolongadas de antibióticos betalactámicos en la población pediátrica

Translated title of the contribution: Continuous and extended infusions of β-Lactam antibiotics in the pediatric population

Mary Covington Walker, Weng Man Lam, Kalen B. Manasco

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

OBJECTIVE: To conduct a systematic review of available data on the use of extended or continuous infusion of b-lactam and monobactam therapy in the pediatric population (aged 0-18 years). DATA SOURCES: A literature search was performed using PubMed (1975-May 2012), International Pharmaceutical Abstracts (1970-May 2012), and Web of Science (1977-May 2012) to identify studies for inclusion. In addition, reference citations from identified publications were reviewed. The following search terms were used: pediatric, children, neonate, infant, adolescent, b-lactam, cephalosporin, carbapenem, penicillin, monobactam, continuous infusion, extended infusion, and/or prolonged infusion. Individual names of drugs in each class of antibiotics were also included in the search. STUDY SELECTION AND DATA EXTRACTION: Randomized controlled clinical trials, pharmacokinetic/pharmacodynamic studies, observational studies, and case reports involving pediatric patients who received extended or continuous infusion of b-lactam or monobactam antibiotics were reviewed. Only English-language publications were included. DATA SYNTHESIS: One randomized controlled clinical trial, 5 pharmacokinetic studies, 2 pharmacodynamic studies using Monte Carlo simulation, 1 case series, and 7 case reports were included in the analysis. The cephalosporin class has been studied the most and currently represents the only clinical trial using a continuous infusion dosing strategy in pediatric patients. There is limited clinical evidence available to support the use of extended or continuous infusion of b-lactam antibiotics in the pediatric population. Pharmacodynamic studies conducted in this population mirror the current evidence in adults for cefepime and meropenem. The single prospective clinical trial using continuous infusion of ceftazidime failed to demonstrate any clinical benefit over traditional dosing; however, there was equal efficacy. CONCLUSIONS: More well-designed prospective clinical trials are required to determine the role of extended or continuous infusion of b-lactam antibiotics in treatment of pediatric patients.

Original languageSpanish
Pages (from-to)1537-1546
Number of pages10
JournalAnnals of Pharmacotherapy
Volume46
Issue number11
DOIs
StatePublished - Nov 1 2012

Fingerprint

Lactams
Monobactams
Pediatrics
Anti-Bacterial Agents
Population
meropenem
Clinical Trials
Cephalosporins
Publications
Randomized Controlled Trials
Pharmacokinetics
Carbapenems
Ceftazidime
PubMed
Penicillins
Pharmaceutical Preparations
Names
Observational Studies
Language
Newborn Infant

Keywords

  • Carbapenem
  • Cephalosporin
  • Monte carlo simulation
  • Penicillin

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Revisión de las infusiones continuas y prolongadas de antibióticos betalactámicos en la población pediátrica. / Walker, Mary Covington; Lam, Weng Man; Manasco, Kalen B.

In: Annals of Pharmacotherapy, Vol. 46, No. 11, 01.11.2012, p. 1537-1546.

Research output: Contribution to journalReview article

Walker, Mary Covington ; Lam, Weng Man ; Manasco, Kalen B. / Revisión de las infusiones continuas y prolongadas de antibióticos betalactámicos en la población pediátrica. In: Annals of Pharmacotherapy. 2012 ; Vol. 46, No. 11. pp. 1537-1546.
@article{553ff4f05eb746bf80f4e742350b51d0,
title = "Revisi{\'o}n de las infusiones continuas y prolongadas de antibi{\'o}ticos betalact{\'a}micos en la poblaci{\'o}n pedi{\'a}trica",
abstract = "OBJECTIVE: To conduct a systematic review of available data on the use of extended or continuous infusion of b-lactam and monobactam therapy in the pediatric population (aged 0-18 years). DATA SOURCES: A literature search was performed using PubMed (1975-May 2012), International Pharmaceutical Abstracts (1970-May 2012), and Web of Science (1977-May 2012) to identify studies for inclusion. In addition, reference citations from identified publications were reviewed. The following search terms were used: pediatric, children, neonate, infant, adolescent, b-lactam, cephalosporin, carbapenem, penicillin, monobactam, continuous infusion, extended infusion, and/or prolonged infusion. Individual names of drugs in each class of antibiotics were also included in the search. STUDY SELECTION AND DATA EXTRACTION: Randomized controlled clinical trials, pharmacokinetic/pharmacodynamic studies, observational studies, and case reports involving pediatric patients who received extended or continuous infusion of b-lactam or monobactam antibiotics were reviewed. Only English-language publications were included. DATA SYNTHESIS: One randomized controlled clinical trial, 5 pharmacokinetic studies, 2 pharmacodynamic studies using Monte Carlo simulation, 1 case series, and 7 case reports were included in the analysis. The cephalosporin class has been studied the most and currently represents the only clinical trial using a continuous infusion dosing strategy in pediatric patients. There is limited clinical evidence available to support the use of extended or continuous infusion of b-lactam antibiotics in the pediatric population. Pharmacodynamic studies conducted in this population mirror the current evidence in adults for cefepime and meropenem. The single prospective clinical trial using continuous infusion of ceftazidime failed to demonstrate any clinical benefit over traditional dosing; however, there was equal efficacy. CONCLUSIONS: More well-designed prospective clinical trials are required to determine the role of extended or continuous infusion of b-lactam antibiotics in treatment of pediatric patients.",
keywords = "Carbapenem, Cephalosporin, Monte carlo simulation, Penicillin",
author = "Walker, {Mary Covington} and Lam, {Weng Man} and Manasco, {Kalen B.}",
year = "2012",
month = "11",
day = "1",
doi = "10.1345/aph.1R216",
language = "Spanish",
volume = "46",
pages = "1537--1546",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "11",

}

TY - JOUR

T1 - Revisión de las infusiones continuas y prolongadas de antibióticos betalactámicos en la población pediátrica

AU - Walker, Mary Covington

AU - Lam, Weng Man

AU - Manasco, Kalen B.

PY - 2012/11/1

Y1 - 2012/11/1

N2 - OBJECTIVE: To conduct a systematic review of available data on the use of extended or continuous infusion of b-lactam and monobactam therapy in the pediatric population (aged 0-18 years). DATA SOURCES: A literature search was performed using PubMed (1975-May 2012), International Pharmaceutical Abstracts (1970-May 2012), and Web of Science (1977-May 2012) to identify studies for inclusion. In addition, reference citations from identified publications were reviewed. The following search terms were used: pediatric, children, neonate, infant, adolescent, b-lactam, cephalosporin, carbapenem, penicillin, monobactam, continuous infusion, extended infusion, and/or prolonged infusion. Individual names of drugs in each class of antibiotics were also included in the search. STUDY SELECTION AND DATA EXTRACTION: Randomized controlled clinical trials, pharmacokinetic/pharmacodynamic studies, observational studies, and case reports involving pediatric patients who received extended or continuous infusion of b-lactam or monobactam antibiotics were reviewed. Only English-language publications were included. DATA SYNTHESIS: One randomized controlled clinical trial, 5 pharmacokinetic studies, 2 pharmacodynamic studies using Monte Carlo simulation, 1 case series, and 7 case reports were included in the analysis. The cephalosporin class has been studied the most and currently represents the only clinical trial using a continuous infusion dosing strategy in pediatric patients. There is limited clinical evidence available to support the use of extended or continuous infusion of b-lactam antibiotics in the pediatric population. Pharmacodynamic studies conducted in this population mirror the current evidence in adults for cefepime and meropenem. The single prospective clinical trial using continuous infusion of ceftazidime failed to demonstrate any clinical benefit over traditional dosing; however, there was equal efficacy. CONCLUSIONS: More well-designed prospective clinical trials are required to determine the role of extended or continuous infusion of b-lactam antibiotics in treatment of pediatric patients.

AB - OBJECTIVE: To conduct a systematic review of available data on the use of extended or continuous infusion of b-lactam and monobactam therapy in the pediatric population (aged 0-18 years). DATA SOURCES: A literature search was performed using PubMed (1975-May 2012), International Pharmaceutical Abstracts (1970-May 2012), and Web of Science (1977-May 2012) to identify studies for inclusion. In addition, reference citations from identified publications were reviewed. The following search terms were used: pediatric, children, neonate, infant, adolescent, b-lactam, cephalosporin, carbapenem, penicillin, monobactam, continuous infusion, extended infusion, and/or prolonged infusion. Individual names of drugs in each class of antibiotics were also included in the search. STUDY SELECTION AND DATA EXTRACTION: Randomized controlled clinical trials, pharmacokinetic/pharmacodynamic studies, observational studies, and case reports involving pediatric patients who received extended or continuous infusion of b-lactam or monobactam antibiotics were reviewed. Only English-language publications were included. DATA SYNTHESIS: One randomized controlled clinical trial, 5 pharmacokinetic studies, 2 pharmacodynamic studies using Monte Carlo simulation, 1 case series, and 7 case reports were included in the analysis. The cephalosporin class has been studied the most and currently represents the only clinical trial using a continuous infusion dosing strategy in pediatric patients. There is limited clinical evidence available to support the use of extended or continuous infusion of b-lactam antibiotics in the pediatric population. Pharmacodynamic studies conducted in this population mirror the current evidence in adults for cefepime and meropenem. The single prospective clinical trial using continuous infusion of ceftazidime failed to demonstrate any clinical benefit over traditional dosing; however, there was equal efficacy. CONCLUSIONS: More well-designed prospective clinical trials are required to determine the role of extended or continuous infusion of b-lactam antibiotics in treatment of pediatric patients.

KW - Carbapenem

KW - Cephalosporin

KW - Monte carlo simulation

KW - Penicillin

UR - http://www.scopus.com/inward/record.url?scp=84869223143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869223143&partnerID=8YFLogxK

U2 - 10.1345/aph.1R216

DO - 10.1345/aph.1R216

M3 - Review article

VL - 46

SP - 1537

EP - 1546

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 11

ER -